December 18, 2013 | Israeli stem cell company Pluristem Therapeutics is moving forward with the agreement reached with Korean company CHA Bio & Diostech signed last June. The two companies have agreed on a strategic partnership which will also include a $10.4 million mutual investment via share swap.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments